Deletion of CFTR Translation Start Site Reveals Functional Isoforms of the Protein in CF Patients

Overview

Journal Cell Physiol Biochem

Specialties Biochemistry
Cell Biology
Pharmacology

Date 2009 Nov 14

PMID 19910674

Citations 23

Authors

Anabela S Ramalho

Marzena A Lewandowska

Carlos M Farinha

Filipa Mendes

Juan Goncalves

Celeste Barreto

Ann Harris

Margarida D Amaral

Affiliations

Soon will be listed here.

Abstract

Background/aims: Mutations in the CFTR gene cause Cystic Fibrosis (CF) the most common life-threatening autosomal recessive disease affecting Caucasians. We identified a CFTR mutation (c.120del23) abolishing the normal translation initiation codon, which occurs in two Portuguese CF patients. This study aims at functionally characterizing the effect of this novel mutation.

Methods: RNA and protein techniques were applied to both native tissues from CF patients and recombinant cells expressing CFTR constructs to determine whether c.120del23 allows CFTR protein production through usage of alternative internal codons, and to characterize the putative truncated CFTR form(s).

Results: Our data show that two shorter forms of CFTR protein are produced when the initiation translation codon is deleted indicating usage of internal initiation codons. The N-truncated CFTR generated by this mutation has decreased stability, very low processing efficiency, and drastically reduced function. Analysis of mutants of four methionine codons downstream to M1 (M82, M150, M152, M156) revealed that each of the codons M150/M152/M156 (exon 4) can mediate CFTR alternative translation.

Conclusions: The CFTR N-terminus has an important role in avoiding CFTR turnover and in rendering effective its plasma membrane traffic. These data correlate well with the severe clinical phenotype of CF patients bearing the c.120del23 mutation.

Citing Articles

Identification and structural analysis for the first mutation in the cystic fibrosis transmembrane conductance regulator protein in Iran: case report and developmental insight using microsatellite markers.

Hosseini Nami A, Kabiri M, Zafarghandi Motlagh F, Shirzadeh T, Bagherian H, Zeinali R Ther Adv Respir Dis. 2024; 18:17534666241253990.

PMID: 38904297 PMC: 11193346. DOI: 10.1177/17534666241253990.

Functional Consequences of CFTR Interactions in Cystic Fibrosis.

Ramananda Y, Naren A, Arora K Int J Mol Sci. 2024; 25(6).

PMID: 38542363 PMC: 10970640. DOI: 10.3390/ijms25063384.

Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.

Thakur S, Ankita , Dash S, Verma R, Kaur C, Kumar R Cell Biochem Biophys. 2023; 82(1):15-34.

PMID: 38048024 DOI: 10.1007/s12013-023-01200-w.

Dietary Na depletion up-regulates NKCC1 expression and enhances electrogenic Cl secretion in rat proximal colon.

Nickerson A, Rajendran V Cell Mol Life Sci. 2023; 80(8):209.

PMID: 37458846 PMC: 11073443. DOI: 10.1007/s00018-023-04857-x.

An ectopic enhancer restores CFTR expression through de novo chromatin looping.

Kerschner J, Paranjapye A, Vaghela N, Wilson M, Harris A Gene Ther. 2022; 30(6):478-486.

PMID: 36510002 PMC: 11227122. DOI: 10.1038/s41434-022-00378-7.

References

Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A . Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998; 101(2):487-96. PMC: 508589. DOI: 10.1172/JCI639. View

Pissarra L, Farinha C, Xu Z, Schmidt A, Thibodeau P, Cai Z . Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol. 2008; 15(1):62-9. DOI: 10.1016/j.chembiol.2007.11.012. View

Du K, Sharma M, Lukacs G . The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol. 2004; 12(1):17-25. DOI: 10.1038/nsmb882. View

Lukaszewicz , Feuermann1 , Jerouville , Stas , BOUTRY . In vivo evaluation of the context sequence of the translation initiation codon in plants. Plant Sci. 2000; 154(1):89-98. DOI: 10.1016/s0168-9452(00)00195-3. View

Sheppard D, Ostedgaard L, Rich D, Welsh M . The amino-terminal portion of CFTR forms a regulated Cl- channel. Cell. 1994; 76(6):1091-8. DOI: 10.1016/0092-8674(94)90385-9. View

Carroll T, Morales M, Fulmer S, Allen S, Flotte T, Cutting G . Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1995; 270(20):11941-6. DOI: 10.1074/jbc.270.20.11941. View

Maquat L . Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol. 2004; 5(2):89-99. DOI: 10.1038/nrm1310. View

Ward C, Kopito R . Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem. 1994; 269(41):25710-8. View

Mendes F, Doucet L, Hinzpeter A, Ferec C, Lipecka J, Fritsch J . Immunohistochemistry of CFTR in native tissues and primary epithelial cell cultures. J Cyst Fibros. 2004; 3 Suppl 2:37-41. DOI: 10.1016/j.jcf.2004.05.008. View

10.

Kozak M . Pushing the limits of the scanning mechanism for initiation of translation. Gene. 2002; 299(1-2):1-34. PMC: 7126118. DOI: 10.1016/s0378-1119(02)01056-9. View

11.

Gadsby D, Vergani P, Csanady L . The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 2006; 440(7083):477-83. PMC: 2720541. DOI: 10.1038/nature04712. View

12.

Chen J, Cutler C, Jacques C, Boeuf G, Denamur E, Lecointre G . A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models. Mol Biol Evol. 2001; 18(9):1771-88. DOI: 10.1093/oxfordjournals.molbev.a003965. View

13.

Lukacs G, Mohamed A, Kartner N, Chang X, Riordan J, Grinstein S . Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 1994; 13(24):6076-86. PMC: 395586. DOI: 10.1002/j.1460-2075.1994.tb06954.x. View

14.

Lewandowska M, Costa F, Bischof J, Williams S, Soares M, Harris A . Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter. Am J Respir Cell Mol Biol. 2009; 43(3):334-41. PMC: 2933549. DOI: 10.1165/rcmb.2009-0149OC. View

15.

Tabcharani J, Chang X, Riordan J, Hanrahan J . Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature. 1991; 352(6336):628-31. DOI: 10.1038/352628a0. View

16.

Farinha C, Nogueira P, Mendes F, Penque D, Amaral M . The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem J. 2002; 366(Pt 3):797-806. PMC: 1222832. DOI: 10.1042/BJ20011717. View

17.

Amaral M . Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis?. Pediatr Pulmonol. 2005; 39(6):479-91. DOI: 10.1002/ppul.20168. View

18.

Cebotaru L, Vij N, Ciobanu I, Wright J, Flotte T, Guggino W . Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and DeltaF508 processing. J Biol Chem. 2008; 283(32):21926-33. PMC: 2494918. DOI: 10.1074/jbc.M709156200. View

19.

Ramalho A, Beck S, Meyer M, Penque D, Cutting G, Amaral M . Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol. 2002; 27(5):619-27. DOI: 10.1165/rcmb.2001-0004OC. View

20.

Thelin W, Chen Y, Gentzsch M, Kreda S, Sallee J, Scarlett C . Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest. 2007; 117(2):364-74. PMC: 1765518. DOI: 10.1172/JCI30376. View